v3.25.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues:    
Net product revenue $ 1,262 $ 1,093
Royalties and other revenue 0 37
Total revenues 1,262 1,130
Operating expenses:    
Cost of sales 30 31
Research and development 15,303 14,372
Selling, general and administrative, including stock-based compensation of $1,469 and $2,708, respectively 11,608 32,060
Total operating expenses 26,941 46,463
Loss from operations (25,679) (45,333)
Interest and other expense  (1,835) (4,948)
Interest income and other, net 2,219 1,884
Net loss $ (25,295) $ (48,397)
Net loss per common share, basic (usd per share) $ (0.07) $ (0.20)
Net loss per common share, diluted (usd per share) $ (0.07) $ (0.20)
Shares used in computing net loss per common share, basic 362,073 245,390
Shares used in computing net loss per common share, diluted 362,073 245,390
Other comprehensive loss:    
Unrealized loss on investments $ (94) $ (81)
Comprehensive loss $ (25,389) $ (48,478)